Pyrazolopyridine compounds and uses thereof
US11795166B2 · kind B2 · utility
1Cited by
47References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2021 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Jan 19, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.